Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Questions on the updated illumina quality score

    The quality of my datum from an updated illumina system is sanger/illumina 1.9 which confused me very much.Could I just treated them as sanger format?
    Can somebody familiar with this can give me some details about this kind of encoding pattern?

  • #2
    Hi zeam,

    I would suggest looking at the changes made to CASAVA 1.8 - there is a nice post about it here.

    I know they have switched the quality encodings from Phred+64 to the more standard Sanger encoding (ASCII = Phred+33) starting in CASAVA 1.8.

    Justin

    Comment


    • #3
      @zeam: The new Illumina quality scores are in Sanger format and encode a Phred quality score from 0 to 93 using ASCII 33 to 126.

      But we are confused with the new quality scores as well. We use BWA for mapping. BWA has the extra option -I for quality scores in the Illumina 1.3+ read format (quality equals ASCII-64). I assume, that without that option BWA expect the old Illumina format. Is that correct? How do we have do use BWA correctly with the new Sanger format?

      Thanks Robby

      Comment


      • #4
        Originally posted by zeam View Post
        The quality of my datum from an updated illumina system is sanger/illumina 1.9 which confused me very much.Could I just treated them as sanger format?
        Can somebody familiar with this can give me some details about this kind of encoding pattern?
        I assume you are referring to pipeline v.1.8 (I am sure there is a v. 1.9 somewhere in illumina labs in alpha/beta testing).
        If that is correct then your quality values will be in sanger format. You will also discover that if your facility uses v.3 chemistry then the valid range of quality values has been expanded beyond the previous max value of 40. You will see quality values of 41 (and up at some point in time), which are now possible.

        Comment


        • #5
          Originally posted by Robby View Post
          But we are confused with the new quality scores as well. We use BWA for mapping. BWA has the extra option -I for quality scores in the Illumina 1.3+ read format (quality equals ASCII-64). I assume, that without that option BWA expect the old Illumina format. Is that correct? How do we have do use BWA correctly with the new Sanger format?
          Not quite. They haven't updated the BWA documentation to say that that 1.3+ should be 1.3-1.7. With 1.8, just don't use the -I and you'll be doing just fine.

          Comment


          • #6
            Hi all,

            I noticed that BWA assigns mapping quality of 0 when it finds a "J" (or at least a bunch of them) in the quality string. So far I've opted for changing al J to I and then map with the default BWA so it assumes is sanger. I think a patch will be needed to correct this bug.

            Let me know if you have observed this as well.

            Comment


            • #7
              Originally posted by GenoMax View Post
              I assume you are referring to pipeline v.1.8 (I am sure there is a v. 1.9 somewhere in illumina labs in alpha/beta testing).
              If that is correct then your quality values will be in sanger format. You will also discover that if your facility uses v.3 chemistry then the valid range of quality values has been expanded beyond the previous max value of 40. You will see quality values of 41 (and up at some point in time), which are now possible.
              Hi,

              Are the scores on a different scale or are there just more of them? I want to filter scores with a cutoff of 20. Previously, with the Phred+64 scores I would test with ASCII-64 > 20. So, can I do this with the Phred+33 scores, such as, ASCII-33 > 20?

              Thanks,
              Thadeous

              Comment

              Latest Articles

              Collapse

              • seqadmin
                Advancing Precision Medicine for Rare Diseases in Children
                by seqadmin




                Many organizations study rare diseases, but few have a mission as impactful as Rady Children’s Institute for Genomic Medicine (RCIGM). “We are all about changing outcomes for children,” explained Dr. Stephen Kingsmore, President and CEO of the group. The institute’s initial goal was to provide rapid diagnoses for critically ill children and shorten their diagnostic odyssey, a term used to describe the long and arduous process it takes patients to obtain an accurate...
                12-16-2024, 07:57 AM
              • seqadmin
                Recent Advances in Sequencing Technologies
                by seqadmin



                Innovations in next-generation sequencing technologies and techniques are driving more precise and comprehensive exploration of complex biological systems. Current advancements include improved accessibility for long-read sequencing and significant progress in single-cell and 3D genomics. This article explores some of the most impactful developments in the field over the past year.

                Long-Read Sequencing
                Long-read sequencing has seen remarkable advancements,...
                12-02-2024, 01:49 PM

              ad_right_rmr

              Collapse

              News

              Collapse

              Topics Statistics Last Post
              Started by seqadmin, 12-17-2024, 10:28 AM
              0 responses
              27 views
              0 likes
              Last Post seqadmin  
              Started by seqadmin, 12-13-2024, 08:24 AM
              0 responses
              43 views
              0 likes
              Last Post seqadmin  
              Started by seqadmin, 12-12-2024, 07:41 AM
              0 responses
              29 views
              0 likes
              Last Post seqadmin  
              Started by seqadmin, 12-11-2024, 07:45 AM
              0 responses
              42 views
              0 likes
              Last Post seqadmin  
              Working...
              X